Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Engelsman

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|July 16, 1988
[Various aspects of 'quality of life' and the treatment of patients with breast cancer]F S Van Dam, N K Aaronson, E Engelsman
European Journal of Cancer|January 1, 1980
CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trialH T Mouridsen, T Palshof, E Engelsman, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 29, 1976
[The treatment of "operable" breast neoplasms; indications for additional therapy]J A van Dongen, E Engelsman, A H Tierie
Journal of Clinical Immunology|September 1, 1988
Production of and response to interleukin-2 in Graves' diseaseZ Eisenstein, E Engelsman, M Weiss, et al.
Clinical and Experimental Immunology|May 1, 1994
Modulation of the IL-2 production defect in vitro in Graves' diseaseZ Eisenstein, E Engelsman, M Weiss, et al.
British Journal of Cancer|August 1, 1974
Proceedings: Oestrogen and androgen receptors in human breast cancerE Engelsman, C B Korsten, J P Persijn, et al.
Archivum Chirurgicum Neerlandicum|January 1, 1973
Human breast cancer and estrogen receptorE Engelsman, C B Korsten, J P Persijn, et al.
British Medical Journal|June 30, 1973
Oestrogen receptor in human breast cancer tissue and response to endocrine therapyE Engelsman, J P Persijn, C B Korsten, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1985
Placental-site trophoblastic tumor: diagnosis, treatment, and biological behaviorA P Heintz, A Schaberg, E Engelsman, et al.
Lancet (London, England)|July 20, 1974
Letter: Anti-oestrogens and breast cancerE Engelsman, C B Korsten, J P Persijn, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Nederlands Tijdschrift Voor Geneeskunde|July 16, 1988
[Various aspects of 'quality of life' and the treatment of patients with breast cancer]F S Van Dam, N K Aaronson, E Engelsman
European Journal of Cancer|January 1, 1980
CMF versus CMF plus tamoxifen in advanced breast cancer in postmenopausal women. An EORTC trialH T Mouridsen, T Palshof, E Engelsman, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 29, 1976
[The treatment of "operable" breast neoplasms; indications for additional therapy]J A van Dongen, E Engelsman, A H Tierie
Journal of Clinical Immunology|September 1, 1988
Production of and response to interleukin-2 in Graves' diseaseZ Eisenstein, E Engelsman, M Weiss, et al.
Clinical and Experimental Immunology|May 1, 1994
Modulation of the IL-2 production defect in vitro in Graves' diseaseZ Eisenstein, E Engelsman, M Weiss, et al.
British Journal of Cancer|August 1, 1974
Proceedings: Oestrogen and androgen receptors in human breast cancerE Engelsman, C B Korsten, J P Persijn, et al.
Archivum Chirurgicum Neerlandicum|January 1, 1973
Human breast cancer and estrogen receptorE Engelsman, C B Korsten, J P Persijn, et al.
British Medical Journal|June 30, 1973
Oestrogen receptor in human breast cancer tissue and response to endocrine therapyE Engelsman, J P Persijn, C B Korsten, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1985
Placental-site trophoblastic tumor: diagnosis, treatment, and biological behaviorA P Heintz, A Schaberg, E Engelsman, et al.
Lancet (London, England)|July 20, 1974
Letter: Anti-oestrogens and breast cancerE Engelsman, C B Korsten, J P Persijn, et al.
Pageof 4